A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers
Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open, single-dose, crossover-design, phase 1, single-center study to
evaluate bioequivalence after administration of L04RD1 or administration of L04TD1 in healthy
volunteers.